|
|
Influencing factors of left ventricular hypertrophy and the predictive value of RDW and hs-CRP in maintenance hemodialysis patients |
LU Jin ZHANG Hongxu ZHANG Yuqin LIU Yiran ZHANG Chaoqun |
Department of Nephrology, Anhui No.2 Provincial People′s Hospital, Anhui Province, Hefei 230011, China |
|
|
Abstract Objective To explore the influencing factors of left ventricular hypertrophy (LVH) and the predictive value of red blood cell distribution width (RDW) and serum hypersensitive C-reactive protein (hs-CRP) in maintenance hemodialysis (MHD) patients. Methods A total of 135 patients with end-stage renal disease who were admitted to Anhui No.2 Provincial People′s Hospital for MHD≥3 months from June 2016 to June 2019 were collected. According to the left ventricular mass index (LVMI), they were divided into LVH group (69 cases) and non-LVH group (66 cases), while patient demographic data, laboratory indicators, and imaging studies were collected. Demographic data, laboratory indicators and imaging examination of each group were collected. Logistic regression was used to analyze the influencing factors of LVH in MHD patients, and the receiver operating characteristic (ROC) curve was drawn to evaluate the predictive value of RDW and hs-CRP to LVH. Results The age, systolic blood pressure, RDW, uric acid, total cholesterol, triacylglycerol, left ventricular end-diastolic diameter and hs-CRP in the LVH group were higher than those in the non-LVH group, and the differences were statistically significant (P < 0.05). Age, systolic blood pressure, history of hypertension, history of diabetes, RDW, hs-CRP were independent risk factors for LVH in MHD patients (P < 0.05). The areas under the curve of RDW and hs-CRP were 0.900 (0.871-0.929) and 0.837 (0.799-0.876), respectively, while the predictive value of joint detection was higher [0.934 (0.913-0.954)]. Conclusion Age, systolic blood pressure, history of hypertension, history of diabetes, RDW and hs-CRP are independent risk factors of LVH in MHD patients. Early combined detection of RDW and hs-CRP has predictive value for LVH in MHD patients.
|
|
|
|
|
[1] 高豆青,单岩,张琳,等.终末期肾脏病患者与主要照顾者疾病不确定感的相关性研究[J].重庆医学,2017,46(8):1145-1148.
[2] 田媚.西那卡塞联合小剂量骨化三醇治疗终末期肾脏病继发性甲状旁腺功能亢进的疗效分析[J].安徽医药,2018, 22(6):1163-1166.
[3] 原成英,周晓霜,李荣山.终末期肾脏病患者血液透析前后血浆鸢尾素水平的变化[J].中华肾脏病杂志,2017,33(12):895-899.
[4] 商惠萍,宋晓萍,李学玲,等.维持性血液透析患者左心室肥厚相关因素分析[J].中国血液净化,2017,16(5):322-325.
[5] Parizadeh SM,Jafarzadeh-Esfehani R,Bahreyni A,et al. The diagnostic and prognostic value of red cell distribution width in cardiovascular disease;current status and prospective [J]. Biofactors,2019,45(4):507-516.
[6] 董建新,王宝芝.高血压患者血清hs-CRP和NT-proBNP水平对左室肥厚的预测意义[J].中国当代医药,2015, 22(19):47-49,52.
[7] 孙宁玲,Jaw-Wen Chen,王继光,等.亚洲高血压合并左心室肥厚诊治专家共识[J].中华高血压杂志,2016,24(7):600,619-627.
[8] 卓建钦.腹膜透析和血液透析对终末期肾病患者心脏结构和功能的影响[J].河北医科大学学报,2019,40(1):38-42.
[9] 林欣然,梁海琴,唐文庄,等.终末期肾病腹膜透析患者血清鸢尾素水平与颈动脉粥样硬化及左心室肥厚相关性研究[J].东南大学学报:医学版,2019,38(2):318-322.
[10] 李茜,丁武杰,范彦君,等.维持性血液透析患者红细胞分布宽度、超敏C反应蛋白与左心室肥厚的临床研究[J].中国中西医结合肾病杂志,2019,20(6):504-507.
[11] 李幼奇,肖少彬,林克宣,等.红细胞分布宽度对增强计算机断层扫描后患者发生对比剂肾病的早期预测价值[J].中华肾脏病杂志,2019,35(6):415-420.
[12] 曾颖,欧阳涵,姜山,等.红细胞分布宽度预测维持性血液透析患者预后的价值[J].中华肾脏病杂志,2019,35(4):259-267.
[13] 黄超越,耿蕾,温向琼,等.红细胞分布宽度对老年维持性血液透析患者预后的预测价值[J].海南医学院学报,2019,25(21):1641-1645.
[14] 刘姗姗,吴桂平,刘兆奕,等.红细胞分布宽度及尿酸与慢性心力衰竭患者左心室肥厚的相关性[J].沈阳医学院学报,2019,21(4):319-322.
[15] 黄炎,黄伟,章爽,等.血清NGAL、hs-CRP、CysC和U-mALB对糖尿病肾病早期诊断价值的初步探讨[J].实用预防医学,2017,24(10):1168-1171.
[16] 苗永国,陈洪涛,侯文华,等.高血压伴左心室肥厚患者TNF-α、IL-6、hs-CRP水平变化及临床意义[J].中西医结合心脑血管病杂志,2015,13(12):1405-1407.
[17] 郭春霞,付丽坤,李默,等.IGF-1、hs-CRP、NT-proBNP与老年2型糖尿病患者左心室肥厚的临床关系[J].中国医药导报,2018,15(11):120-122,142.
[18] 高敏,许娴,周玉君,等.终末期肾病非透析患者左心室肥厚的危险因素分析[J].中华肾脏病杂志,2019,35(10):736-740.
[19] 尹纪来,高飞,李浩,等.平均血小板体积/血小板计数比值与原发性高血压患者左心室肥厚的相关性[J].中国医药导报,2019,16(22):166-169.
[20] 廖礼强,程军,刘廷容,等.中青年H型高血压患者左心室肥厚的影响因素分析[J].重庆医学,2019,48(24):4165-4168.
[21] 刘长清,樊光辉.射血分数保留的心力衰竭合并2型糖尿病患者的临床特征分析[J].中国心血管杂志,2018, 23(3):251-255. |
|
|
|